We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Faviton

News List

Brinton Pharma triples production of favipiravir expresspharma
May 14, 2021
Brinton Pharmaceuticals informed that it has more than tripled up the production of Faviton (Favipiravir 400) tablets. Favipiravir is used as an oral antiviral therapy for mild to moderate cases of COVID-19.
Brinton Pharma gets DCGI nod for Faviton 400 mg expresspharma
August 21, 2020
Brinton Pharmaceuticals has received approval from Drugs Controller General of India (DCGI) for the launch of Favipiravir 400mg under the brand name Faviton.
Brinton Pharmaceuticals gets DCGI’s approval to launch favipiravir anti-viral tablets in India expresspharma
July 24, 2020
Brinton Pharmaceuticals has received approval from Drugs Controller General of India (DCGI) to market favipiravir under the brand name faviton.